简体中文 | 繁體中文 | English

CBI CN 2012 120

6th China Human&Veterinary Vaccine Industry Summit 2014

July 4th-5th Changchun, China

2014-05-29 09:00
  • zh_cn
  • zh_hant
  • en

SHANGHAI--(Business Wire)--The 6th China Human&Veterinary Vaccine Industry Summit 2014 will be held on July 4th-5th in Changchun, China.

 

Since 2009, CBI Pharma has continuously held China Vaccine Industry Summit for five years. Based on topics like policies, marketing changes, techniques and collaboration, CBI provides a platform for leaders from Governments, Manufactures, Institutions, Equipment providers, Pes & VCs and other related enterprises.

 

Human Vaccine:

In the aspect of human vaccine, promoted by China’s National Immunization Scheme over years, the rate of group-one vaccines under the scheme rises, which effectively prevent the newborns and children from infection of epidemic diseases. Meanwhile, the variety of vaccines increases and leads to market expansion in short time. As related data show, China's vaccine market has sustained a 15% annual growth. However, the market expansion brings more challenges for Chinese vaccine production enterprises. The emergence of new epidemic diseases, such as H7N9, questioned vaccine enterprises’ emergency R&D ability. Safety accidents of vaccine occur from time to time, which asks the industry to put more effective control on manufacturing, QC, storage, transportation, etc. And the homogenized competition leads enterprises and research institutes to improve technology to ehance the immune effect.

 

Topics and speakers include:

Keynote Speech: Analysis of Epidemic Tendency in China and over the World and National Immunization Control Strategy

Speaker: National Immunization Program Chinese Center for Disease Control and Prevention

Keynote Speech: Current Situation of China’s Vaccine Industry and Environment for Innovation

Speaker: R&D Department, China National Biotec Group

Keynote Speech: Changes of New Pharmacopoeia in Vaccine

Speaker: Division of Enteric Bacterial Vaccines, NIFDC

Keynote Speech: Influenza Vaccine Production Process Management

Speaker: Head of China Industrial Operations, Sanofi Pasteur

Keynote Speech: Development of Vaccine Formulation

Speaker: Shanghai Zerun Biotech Co.,Ltd

 

Apart from above topics, we will also focus on Construction and Application of New Vaccine Vectors, Innovative Vaccine Technology Platform, Conjugate Vaccines, Therapeutic Vaccine, etc. Also, as the development of GSK and MERCK’s HPV vaccines in China gains more attention, a panel discussion on collaboration among domestic and multinational enterprises and related government departments will be arranged.

 

Veterinary Vaccine:

With the human vaccine market expanding, the veterinary vaccine industry also faces great opportunities and challenges. At present, there are over 100 animal vaccine manufacturers in China, with more than 300 production lines. However, most of the enterprises are small in scale, with unqualified vaccine production inspection and poor product structures. The market is dominated by a minority of enterprises.

 

On one hand, China’s Ministry of Agriculture and Ministry of Finance made the 2013 National Compulsory Immunization Program for Animal Diseases, which requires compulsory immunization for animal diseases including highly pathogenic avian influenza, foot-and-mouth disease, highly pathogenic blue-ear disease and swine fever. This makes the veterinary vaccine market expand. On the other hand, foreign enterprises, like BI, steps into China by setting up manufacture bases. The development of sino-foreign joint venture enterprises brings more competition and challenge for manufacturing and quality control. Under the situation, it is important to learn the industry development, adjust company strategies, cooperate with industry leaders and collaborate with foreign companies. Therefore, with the support of China Animal Husbandry Group,Yangzhou University, Changchun Veterinary Research Institute from Academy of Military Medical Science, this vaccine summit will be a great communication platform.

 

Topics include

Keynote Speech: Veterinary Vaccine Market Trends

Speaker: Mr. Qiyi HU, Vice President, China Animal Husbandry Group

Keynote Speech: Infection Trend and Vaccine Control Strategy of Swine Fever

Speaker: Mr. Huaji QIU, Researcher, Harbin Veterinary Research Institute, CAAS

Keynote Speech: Bird Flu Virus and Vaccine Improvement

Speaker:Yangzhou University

 

Contacts:

CBI BIZ

Tel: +86 21 5155 1610

Fax: +86 21 5155 2421

Human Vaccine:

Sally Shen, sallyshen@cbichina.com

Veterinary Vaccine:

Abby Zeng, abbyzeng@cbichina.com

Website: http://vaccine.cbibiz.com/51211/index.html